204 related articles for article (PubMed ID: 11556024)
1. Mucopolysaccharidosis type I: clinical and biochemical study.
Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
[TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
[TBL] [Abstract][Full Text] [Related]
3. [Mucopolysaccharidosis type I in the Cuban population].
Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
[TBL] [Abstract][Full Text] [Related]
4. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
5. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
[TBL] [Abstract][Full Text] [Related]
6. [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families].
Chkioua L; Khedhiri S; Jaidane Z; Ferchichi S; Habib S; Froissart R; Bonnet V; Chaabouni M; Dandana A; Jrad T; Limem H; Maire I; Abdelhedi M; Laradi S
Arch Pediatr; 2007 Oct; 14(10):1183-9. PubMed ID: 17728118
[TBL] [Abstract][Full Text] [Related]
7. The clinical spectrum of alpha-L-iduronidase deficiency.
Roubicek M; Gehler J; Spranger J
Am J Med Genet; 1985 Mar; 20(3):471-81. PubMed ID: 3922223
[TBL] [Abstract][Full Text] [Related]
8. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
9. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
[TBL] [Abstract][Full Text] [Related]
10. Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
Aldenhoven M; de Koning TJ; Verheijen FW; Prinsen BH; Wijburg FA; van der Ploeg AT; de Sain-van der Velden MG; Boelens J
Biol Blood Marrow Transplant; 2010 May; 16(5):701-4. PubMed ID: 20096360
[TBL] [Abstract][Full Text] [Related]
11. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
Mueller OT; Shows TB; Opitz JM
Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
[TBL] [Abstract][Full Text] [Related]
12. [Ocular Manifestation of Mucopolysaccharidosis I-S (Scheie's Syndrome)].
Viestenz A; Shin YS; Viestenz A; Naumann GO
Klin Monbl Augenheilkd; 2002 Oct; 219(10):745-8. PubMed ID: 12447720
[TBL] [Abstract][Full Text] [Related]
13. [Mental retardation revealing mucopolysaccharidosis type I in a child treated for cystic fibrosis: a case report].
Scheidecker S; Vodoff-Oehler MV; Issa-Brunet L; Peralta MF
Arch Pediatr; 2011 Dec; 18(12):1324-6. PubMed ID: 22030348
[TBL] [Abstract][Full Text] [Related]
14. Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.
Pereira VG; Martins AM; Micheletti C; D'Almeida V
Clin Chim Acta; 2008 Jan; 387(1-2):75-9. PubMed ID: 17920576
[TBL] [Abstract][Full Text] [Related]
15. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic strategy of mucopolysaccharidosis type I in Tunisia].
Chkioua L; Ferchichi S; Khedhiri S; Laradi S; Bibi A; Amira D; Dandana A; Ben Mansour R; Ben Limam H; Chaabouni M; Froissart R; Maire I; Miled A
Ann Biol Clin (Paris); 2007; 65(2):175-9. PubMed ID: 17353172
[TBL] [Abstract][Full Text] [Related]
17. Hurler syndrome: alpha-L-iduronidase activity in leukocytes as a method for heterozygote detection.
Wappner RS; Brandt IK
Pediatr Res; 1976 Jun; 10(6):629-32. PubMed ID: 818611
[TBL] [Abstract][Full Text] [Related]
18. Prediction of neuropathology in mucopolysaccharidosis I patients.
Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191
[TBL] [Abstract][Full Text] [Related]
19. [Mucopolysaccharidosis IS: Scheie's syndrome. A report of 2 brothers].
Bonora G; Frattini D; Nedbal M; Massironi C; Perletti L
Pediatr Med Chir; 1991; 13(6):631-6. PubMed ID: 1839643
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-replacement therapy in mucopolysaccharidosis I.
Kakkis ED; Muenzer J; Tiller GE; Waber L; Belmont J; Passage M; Izykowski B; Phillips J; Doroshow R; Walot I; Hoft R; Neufeld EF
N Engl J Med; 2001 Jan; 344(3):182-8. PubMed ID: 11172140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
